NADEZHDA KRAVCHUK: Open Payments
NPI 1033686076 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 26 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $762 · 2025 $608
Food & beverage: $528Education: $80
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 8 | $202 |
| GENZYME CORPORATION | 3 | $84 |
| ABBVIE INC. | 4 | $81 |
| Janssen Biotech, Inc. | 1 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $15 |
| UCB, Inc. | 1 | $14 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, COSENTYX, NEMLUVIO, DYSPORT, Sotyktu, Zoryve.
Industry payments across ID — which companies pay providers there.
